Published in Nucleic Acids Res on February 25, 1987
mRNA stability in mammalian cells. Microbiol Rev (1995) 8.78
Identification and comparison of stable and unstable mRNAs in Saccharomyces cerevisiae. Mol Cell Biol (1990) 5.47
The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol Cell Biol (1995) 4.76
Poly(A) shortening and degradation of the 3' A+U-rich sequences of human c-myc mRNA in a cell-free system. Mol Cell Biol (1988) 3.96
UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type 1, collagenase, c-fos, and metallothionein. Mol Cell Biol (1989) 3.83
Interplay of two functionally and structurally distinct domains of the c-fos AU-rich element specifies its mRNA-destabilizing function. Mol Cell Biol (1994) 2.93
Regulation of c-fos gene expression in hamster fibroblasts: initiation and elongation of transcription and mRNA degradation. Nucleic Acids Res (1987) 2.87
Determinants that contribute to cytoplasmic stability of human c-fos and beta-globin mRNAs are located at several sites in each mRNA. Mol Cell Biol (1988) 2.46
U-rich sequence-binding proteins (URBPs) interacting with a 20-nucleotide U-rich sequence in the 3' untranslated region of c-fos mRNA may be involved in the first step of c-fos mRNA degradation. Mol Cell Biol (1992) 2.40
Autoregulation of fos: the dyad symmetry element as the major target of repression. EMBO J (1989) 2.37
Multiple sequence elements of a single functional class are required for cyclic AMP responsiveness of the mouse c-fos promoter. Mol Cell Biol (1989) 2.20
Poly(A) tail shortening is the translation-dependent step in c-myc mRNA degradation. Mol Cell Biol (1990) 2.06
Translation and the stability of mRNAs encoding the transferrin receptor and c-fos. Proc Natl Acad Sci U S A (1991) 1.93
Protein synthesis inhibitors differentially superinduce c-fos and c-jun by three distinct mechanisms: lack of evidence for labile repressors. EMBO J (1992) 1.91
RNAPol-ChIP: a novel application of chromatin immunoprecipitation to the analysis of real-time gene transcription. Nucleic Acids Res (2004) 1.86
UV-induced activation of AP-1 involves obligatory extranuclear steps including Raf-1 kinase. EMBO J (1993) 1.86
Two different RNA binding activities for the AU-rich element and the poly(A) sequence of the mouse neuronal protein mHuC. Nucleic Acids Res (1996) 1.77
Activation of the transforming potential of the human fos proto-oncogene requires message stabilization and results in increased amounts of partially modified fos protein. Mol Cell Biol (1988) 1.70
The chicken dystrophin cDNA: striking conservation of the C-terminal coding and 3' untranslated regions between man and chicken. EMBO J (1988) 1.65
Transcriptional activation of cellular oncogenes fos, jun, and myc by human cytomegalovirus. J Virol (1991) 1.61
Transcriptional consequences of topoisomerase inhibition. Mol Cell Biol (2001) 1.55
Fos C-terminal mutations block down-regulation of c-fos transcription following serum stimulation. EMBO J (1988) 1.54
Activation of p53 in cervical carcinoma cells by small molecules. Proc Natl Acad Sci U S A (2000) 1.52
The down-regulation of the chicken cytoplasmic beta actin during myogenic differentiation does not require the gene promoter but involves the 3' end of the gene. Nucleic Acids Res (1988) 1.46
UV-Induced stabilization of c-fos and other short-lived mRNAs. Mol Cell Biol (2000) 1.35
The destabilizing elements in the coding region of c-fos mRNA are recognized as RNA. Mol Cell Biol (1993) 1.34
Nucleotide sequence of testis-derived c-abl cDNAs: implications for testis-specific transcription and abl oncogene activation. Proc Natl Acad Sci U S A (1987) 1.31
Regulation of the mRNA for monocyte-derived neutrophil-activating peptide in differentiating HL60 promyelocytes. Mol Cell Biol (1989) 1.31
A high throughput screening for rarely transcribed differentially expressed genes. Nucleic Acids Res (1997) 1.30
Two cellular proteins bind specifically to a purine-rich sequence necessary for the destabilization function of a c-fos protein-coding region determinant of mRNA instability. Mol Cell Biol (1992) 1.27
Complete thrombospondin mRNA sequence includes potential regulatory sites in the 3' untranslated region. J Cell Biol (1989) 1.22
Regulation of 4F2 heavy-chain gene expression during normal human T-cell activation can be mediated by multiple distinct molecular mechanisms. Mol Cell Biol (1988) 1.22
Target specificity of neuronal RNA-binding protein, Mel-N1: direct binding to the 3' untranslated region of its own mRNA. Nucleic Acids Res (1996) 1.21
Inducibility of the DNA repair gene encoding O6-methylguanine-DNA methyltransferase in mammalian cells by DNA-damaging treatments. Mol Cell Biol (1991) 1.19
A phorbol ester-regulated ribonuclease system controlling transforming growth factor beta 1 gene expression in hematopoietic cells. Mol Cell Biol (1990) 1.17
Mouse Zfx protein is similar to Zfy-2: each contains an acidic activating domain and 13 zinc fingers. Mol Cell Biol (1990) 1.15
Transcriptional and posttranscriptional control of c-fos gene expression in human monocytes. Mol Cell Biol (1988) 1.15
Rapid c-myc mRNA degradation does not require (A + U)-rich sequences or complete translation of the mRNA. Nucleic Acids Res (1991) 1.06
Strong and prolonged induction of c-jun and c-fos proto-oncogenes by photodynamic therapy. Br J Cancer (1996) 1.00
Analysis of the rat JE gene promoter identifies an AP-1 binding site essential for basal expression but not for TPA induction. Nucleic Acids Res (1990) 1.00
Analysis of polyadenylation site usage of the c-myc oncogene. Nucleic Acids Res (1989) 1.00
Regulation of c-fos and c-jun protooncogene expression by the Ca(2+)-ATPase inhibitor thapsigargin. Proc Natl Acad Sci U S A (1991) 0.98
5' untranslated sequences modulate rapid mRNA degradation mediated by 3' AU-rich element in v-/c-fos recombinants. Nucleic Acids Res (1992) 0.98
A model of liver regeneration. Biophys J (2009) 0.95
A novel effect of EGF on mRNA stability. Nucleic Acids Res (1988) 0.94
Protein synthesis inhibitors, gene superinduction and memory: too little or too much protein? Neurobiol Learn Mem (2007) 0.93
A new cAMP response element in the transcribed region of the human c-fos gene. Nucleic Acids Res (1991) 0.92
Identification of rapid turnover transcripts overexpressed in thyroid tumors and thyroid cancer cell lines: use of a targeted differential RNA display method to select for mRNA subsets. Nucleic Acids Res (1997) 0.91
Differential regulation of interleukin-6 receptor and gp130 gene expression in rat hepatocytes. Mol Biol Cell (1992) 0.91
Metal-specific posttranscriptional control of human metallothionein genes. Mol Cell Biol (1989) 0.91
UV-induced early-domain binding factor as the limiting component of simian virus 40 DNA amplification in rodent cells. Mol Cell Biol (1989) 0.88
Response modification in carcinogenesis. Environ Health Perspect (1989) 0.86
A model for generating circadian rhythm by coupling ultradian oscillators. Theor Biol Med Model (2006) 0.83
GnRH increases c-Fos half-life contributing to higher FSHβ induction. Mol Endocrinol (2012) 0.83
Barriers to transmission of transcriptional noise in a c-fos c-jun pathway. Mol Syst Biol (2013) 0.80
Overexpression of the alpha-type protein kinase (PK) C in LLC-PK1 cells does not lead to a proportional increase in the induction of two 12-O-tetradecanoylphorbol-13-acetate-inducible genes. Cell Regul (1991) 0.78
Induction of manganese superoxide dismutase mRNA by okadaic acid and protein synthesis inhibitors. Biochem J (1994) 0.78
5-HT2C receptor desensitization moderates anxiety in 5-HTT deficient mice: from behavioral to cellular evidence. Int J Neuropsychopharmacol (2014) 0.77
Impairment of FOS mRNA stabilization following translation arrest in granulocytes from myelodysplastic syndrome patients. PLoS One (2013) 0.76
Alternative splicing of c-fos pre-mRNA: contribution of the rates of synthesis and degradation to the copy number of each transcript isoform and detection of a truncated c-Fos immunoreactive species. BMC Mol Biol (2007) 0.76
Reduction of c-Fos via Overexpression of miR-34a Results in Enhancement of TNF- Production by LPS in Neutrophils from Myelodysplastic Syndrome Patients. PLoS One (2016) 0.75
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet (1982) 54.79
A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell (1986) 36.96
Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature (1984) 24.45
Rat insulin genes: construction of plasmids containing the coding sequences. Science (1977) 17.05
Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5' element and c-fos 3' sequences. Cell (1985) 10.00
Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature (1985) 9.73
Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell (1983) 9.03
Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein. Nature (1985) 8.36
Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IIA gene. Nature (1984) 7.57
FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA. J Virol (1982) 6.11
Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini. Cell (1983) 5.79
c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene. Cell (1984) 5.55
Effect of protein synthesis inhibitors on growth factor activation of c-fos, c-myc, and actin gene transcription. Mol Cell Biol (1986) 5.07
Viral and cellular fos proteins: a comparative analysis. Cell (1984) 4.89
Expression of the c-fos gene and of an fos-related gene is stimulated by platelet-derived growth factor. Science (1984) 4.87
The heat shock response is self-regulated at both the transcriptional and posttranscriptional levels. Cell (1982) 4.62
Differential expression of cellular oncogenes during pre- and postnatal development of the mouse. Nature (1982) 4.44
Mouse actin messenger RNAs. Construction and characterization of a recombinant plasmid molecule containing a complementary DNA transcript of mouse alpha-actin mRNA. J Biol Chem (1981) 4.30
Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia. Nature (1984) 4.29
Rapid induction of the expression of proto-oncogene fos during human monocytic differentiation. Cell (1985) 3.81
Superinduction of c-fos by nerve growth factor in the presence of peripherally active benzodiazepines. Science (1985) 3.15
Virus induction of osteosarcomas in mice. Science (1966) 2.96
Removal of a 67-base-pair sequence in the noncoding region of protooncogene fos converts it to a transforming gene. Proc Natl Acad Sci U S A (1985) 2.95
Platelet-derived growth factor and double-stranded ribonucleic acids stimulate expression of the same genes in 3T3 cells. Cell (1985) 2.82
Analysis of interferon mRNA in human fibroblast cells induced to produce interferon. Proc Natl Acad Sci U S A (1981) 2.77
Induction of the proto-oncogene fos by nerve growth factor. Proc Natl Acad Sci U S A (1985) 2.74
Induction of metallothionein and other mRNA species by carcinogens and tumor promoters in primary human skin fibroblasts. Mol Cell Biol (1986) 2.63
Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells. Proc Natl Acad Sci U S A (1985) 2.35
Induction of c-fos during myelomonocytic differentiation and macrophage proliferation. Nature (1985) 2.34
Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes. Nature (1984) 2.34
Analysis of the differentiation-promoting potential of inducible c-fos genes introduced into embryonal carcinoma cells. EMBO J (1985) 2.11
Expression of c-onc genes: c-fos transcripts accumulate to high levels during development of mouse placenta, yolk sac and amnion. EMBO J (1983) 2.08
c-fos expression is neither sufficient nor obligatory for differentiation of monomyelocytes to macrophages. Cell (1986) 1.87
Differential expression of c-fos in hematopoietic cells: correlation with differentiation of monomyelocytic cells in vitro. EMBO J (1984) 1.63
Interferon-gamma, mitomycin C, and cycloheximide as regulatory agents of MHC class II-associated invariant chain expression. J Immunol (1986) 1.20
A deletion of the 3' end of the Drosophila melanogaster hsp70 gene increases stability of mutant mRNA during recovery from heat shock. Mol Cell Biol (1985) 1.20
Enhanced expression of c-myc and decreased expression of c-fos protooncogenes in chemically and radiation-transformed C3H/10T1/2 Cl 8 mouse embryo cell lines. Cancer Res (1986) 1.05
Hormonal regulation of cell surface expression of the major histocompatibility antigen H-2Ld in transfected cells. EMBO J (1985) 0.99
Post-transcriptional regulation of albumin gene expression in Xenopus liver. EMBO J (1985) 0.87
The nuclear receptor superfamily: the second decade. Cell (1995) 24.99
Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell (1987) 20.61
Easy identification of cDNA clones. EMBO J (1983) 9.18
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell (1991) 7.29
Steroid hormone receptors: many actors in search of a plot. Cell (1995) 7.22
Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell (1991) 6.89
Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell (1990) 6.56
pUR222, a vector for cloning and rapid chemical sequencing of DNA. Nucleic Acids Res (1981) 6.55
Sequence of the lacZ gene of Escherichia coli. EMBO J (1983) 6.46
DNA binding of the glucocorticoid receptor is not essential for survival. Cell (1998) 6.40
Conjugation proteins encoded by the F sex factor. Nature (1977) 5.23
12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region. Mol Cell Biol (1987) 4.86
Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J (1987) 4.56
Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature (1989) 4.42
ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J (1995) 4.28
Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun. Cell (1989) 4.17
Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell (1988) 4.13
Bone and haematopoietic defects in mice lacking c-fos. Nature (1993) 4.07
UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type 1, collagenase, c-fos, and metallothionein. Mol Cell Biol (1989) 3.83
Programmed cell death is affected in the novel mouse mutant Fused toes (Ft). Development (1994) 3.71
Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci U S A (1986) 3.68
The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev (2001) 3.65
Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev (1999) 3.51
Subfragments of the large terminal repeat cause glucocorticoid-responsive expression of mouse mammary tumor virus and of an adjacent gene. Proc Natl Acad Sci U S A (1983) 3.42
pUR 250 allows rapid chemical sequencing of both DNA strands of its inserts. Nucleic Acids Res (1982) 3.40
Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem J (1986) 3.31
Export without proteolytic processing of inner and outer membrane proteins encoded by F sex factor tra cistrons in Escherichia coli minicells. Proc Natl Acad Sci U S A (1979) 3.31
Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J (1993) 3.28
Serum response factor is essential for mesoderm formation during mouse embryogenesis. EMBO J (1998) 3.27
Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J Biol Chem (1999) 3.17
CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet (1995) 3.07
Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science (1992) 3.05
Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. EMBO J (1993) 2.83
Construction and properties of a new cloning vehicle, allowing direct screening for recombinant plasmids. Mol Gen Genet (1980) 2.80
Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex. Mol Cell Biol (1990) 2.73
Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid. Oncogene (2001) 2.67
Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro. Oncogene (1995) 2.64
Induction of metallothionein and other mRNA species by carcinogens and tumor promoters in primary human skin fibroblasts. Mol Cell Biol (1986) 2.63
A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J (1994) 2.58
Structure and chromosomal localization of the functional intronless human JUN protooncogene. Proc Natl Acad Sci U S A (1988) 2.51
Long terminal repeats of endogenous mouse mammary tumour virus contain a long open reading frame which extends into adjacent sequences. Nature (1982) 2.48
Activation of the c-fos gene by UV and phorbol ester: different signal transduction pathways converge to the same enhancer element. Oncogene (1988) 2.43
Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res (1993) 2.39
Autoregulation of fos: the dyad symmetry element as the major target of repression. EMBO J (1989) 2.37
CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res (1991) 2.36
c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin. Cell (2000) 2.35
Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J (2001) 2.34
Immunoenzymatic detection of expressed gene fragments cloned in the lac Z gene of E. coli. EMBO J (1982) 2.29
Involvement of growth factor receptors in the mammalian UVC response. Cell (1994) 2.28
Different requirements for formation of Jun: Jun and Jun: Fos complexes. Genes Dev (1989) 2.22
Analysis of the differentiation-promoting potential of inducible c-fos genes introduced into embryonal carcinoma cells. EMBO J (1985) 2.11
The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res (1996) 2.09
Deregulated c-fos expression interferes with normal bone development in transgenic mice. Nature (1987) 2.08
Exon cloning: immunoenzymatic identification of exons of the chicken lysozyme gene. Proc Natl Acad Sci U S A (1982) 2.07
A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol (1993) 2.06
Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med (1993) 2.03
A novel function of the transforming domain of E1a: repression of AP-1 activity. Cell (1990) 1.97
DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation. Oncogene (1999) 1.96
Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. EMBO J (1996) 1.96
Inducible expression and phosphorylation of coactivator BOB.1/OBF.1 in T cells. Science (1997) 1.93
Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator. EMBO J (1998) 1.93
Regulation of synthesis of a major outer membrane protein: cyclic AMP represses Escherichia coli protein III synthesis. Proc Natl Acad Sci U S A (1979) 1.93
Cloning of Fatso (Fto), a novel gene deleted by the Fused toes (Ft) mouse mutation. Mamm Genome (1999) 1.92
Rescue of the albino phenotype by introduction of a functional tyrosinase gene into mice. EMBO J (1990) 1.91
UV-induced activation of AP-1 involves obligatory extranuclear steps including Raf-1 kinase. EMBO J (1993) 1.86
Regional expression of the homeobox gene Nkx-2.2 in the developing mammalian forebrain. Neuron (1992) 1.85
Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway. EMBO J (2001) 1.83
CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res (1999) 1.82
UV-induced extracellular factor from human fibroblasts communicates the UV response to nonirradiated cells. Cell (1984) 1.80
Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol (1994) 1.79
The Fos and Jun/AP-1 proteins are involved in the downregulation of Fos transcription. Oncogene (1989) 1.78
CREB is activated by UVC through a p38/HOG-1-dependent protein kinase. EMBO J (1997) 1.78